The interaction of caffeine with Leucine rich repeat kinase 2 (LRRK2) genetic risk variants in Asians.
APONTIS PHARMA shareholders can tender their shares from today – Offer Document published – Biotech Investments
EQS-News: Zentiva AG / Key word(s): Mergers & Acquisitions APONTIS PHARMA shareholders can tender their shares from today – Offer Document published 24.10.2024 / 08:15